Tissue-engineered vascular grafts: does cell seeding matter?

Journal of Pediatric Surgery

Volumn 45, Issue 6, 2010, Pages 1299-1305

  Mirensky, Tamar L ^a,b   Hibino, Narutoshi ^b   Sawh Martinez, Rajendra F ^b   Yi, Tai ^b   Villalona, Gustavo ^b   Shinoka, Toshiharu ^a,b   Breuer, Christopher K ^a,b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell seeding; Mononuclear cells; Tissue engineering; Vascular conduit; Vascular graft

Indexed keywords

CD31 ANTIGEN; COLLAGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; BONE MARROW; BONE MARROW CELL; CELL ACTIVITY; CELL ISOLATION; CELL POPULATION; CELL SEEDING; CONGENITAL HEART MALFORMATION; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; GRAFT PATENCY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMPLANTATION; INFERIOR CAVA VEIN; MICRO-COMPUTED TOMOGRAPHY; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SMOOTH MUSCLE FIBER; TISSUE ENGINEERED VASCULAR GRAFT; TISSUE ENGINEERING; ANIMAL; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GRAFT SURVIVAL; PHYSIOLOGY; PROSTHESIS; SCID MOUSE; TISSUE SCAFFOLD; TRANSPLANTATION; VASCULAR PATENCY;

ANIMALS; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MONOCYTES; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR PATENCY; VENA CAVA, INFERIOR;

EID: 77953849571     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.02.102     Document Type: Article

References (11)

1. Watanabe M., Shin'oka T., Tohyama S., et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 7 (2001) 429-439
2. Cho S.W., Park H.J., Ryu J.H., et al. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 26 (2005) 1915-1924
3. Matsumura G., Miyagawa-Tomita S., Shin'oka T., et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108 (2003) 1729-1734
4. Shin'oka T., Matsumura G., Hibino N., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338
5. Goyal A., Wang Y., Su H., et al. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J Pediatr Surg 41 (2006) 787-791
6. Roh J.D., nelson G.N., Brennan M.P., et al. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 29 (2008) 1454-1462
7. Mirensky T.L., Nelson G.N., Brennan M.P., et al. Tissue-engineered arterial grafts: long term results after implantation in a small animal model. J Pediatr Surg 44 (2009) 1127-1133
8. Brennan M.P., Dardik A., Hibino N., et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 248 (2008) 370-377
9. Salcedo R., Ponce M.L., Young H.A., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96 (2000) 34-40
10. Nelson G.N., Roh J.D., Mirensky T.L., et al. Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB J 22 (2008) 3888-3895
11. Nelson G.N., Mirensky T.L., Brennan M.P., et al. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. Arch Surg 143 (2008) 488-494